Argitalpenak (82) ALIPIO MANGAS ROJAS argitalpenak

2024

  1. Implementing a New Algorithm for Reinterpretation of Ambiguous Variants in Genetic Dilated Cardiomyopathy

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

  2. Role of miRNA–mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy

    Biomedicines, Vol. 12, Núm. 8

2023

  1. Next-generation sequencing reveals genetic differences between two distinct etiologies of dilated cardiomyopathy

    Atherosclerosis, Vol. 379, pp. S179

  2. Transcriptome analysis of miRNA and mRNA in the myocardial tissue of mice with LMNA-dilated cardiomyopathy

    Atherosclerosis, Vol. 379, pp. S179-S180

  3. miR-130b-3p alleviates palmitate-induced lipotoxicity via the PPARυ signaling pathway in cardiomyocytes

    Atherosclerosis, Vol. 379, pp. S177

2022

  1. A microRNA Signature for the Diagnosis of Statins Intolerance

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Impact of COVID-19 on Physical Activity and Lifestyles in Post-Confinement Sports Science Undergraduates

    International journal of environmental research and public health, Vol. 19, Núm. 15

  3. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

2021

  1. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1711-1725

  2. Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 740-749

  3. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  2. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic

    European Journal of Clinical Investigation, Vol. 50, Núm. 12

  3. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2019

  1. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy

    Bioscience Reports, Vol. 39, Núm. 3

2018

  1. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society

    Journal of Clinical Lipidology, Vol. 12, Núm. 6, pp. 1482-1492.e3

  2. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy

    Journal of Molecular Medicine, Vol. 96, Núm. 8, pp. 845-856

2017

  1. Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers

    International Journal of Cardiology, Vol. 228, pp. 870-880

2016

  1. Cardiometabolic risk in patients with chronic renal disease related to hypertriglyceridemia-low HDL -cholesterol association

    Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

  2. Do diet and exercise influence in an athletic population?: New clues of the entero-insular axis

    Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice